https://www.zacks.com/stock/news/2247400/pharma-stock-roundup-abbv-nvo-s-new-m-as-fda-nod-to-jnj-mrk-pah-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-2247400
Mar 28, 2024 - While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs.
zc:-4251459591006756089
0
https://www.zacks.com/stock/news/2245572/adtran-adtn-unveils-fsp-3000-m-flex800-for-network-operators?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2245572
Mar 25, 2024 - ADTRAN (ADTN) FSP3000 M-Flex800 leverages ZR and ZR+ pluggable optics and empowers operators to match high-capacity connectivity needs across a diverse range of applications.
zc:3783190185095676526
0
https://www.zacks.com/stock/news/2242390/looking-for-a-growth-stock-3-reasons-why-m-nchener-r-ckversicherungs-gesellschaft-murgy-is-a-solid-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2242390
Mar 18, 2024 - M?nchener R?ckversicherungs-Gesellschaft (MURGY) possesses solid growth attributes, which could help it handily outperform the market.
zc:8978530638437866937
0
https://seekingalpha.com/news/4077812-patent-cliffs-could-fuel-increased-ma-in-oncology-this-year-cantor-says?source=feed_sector_healthcare
Mar 10, 2024 - Cantor Fitzgerald sees a strong year for oncology M&A as major drugmakers look to replenish pipelines ahead of steep patent cliffs for top-selling products. Read more here.
0
sa:-7757032918485398630
0
https://seekingalpha.com/article/4675859-mi-homes-there-are-better-alternatives-in-the-homebuilding-industry?source=feed_all_articles
Mar 04, 2024 - M/I Homes has seen a significant increase in its stock price, outperforming the broader market over past 12-month period. See why I'm neutral on MHO stock.
0
sa:7492793654119547691
0
https://www.startribune.com/datasite-buys-swiss-company-sherpany-ma-services/600346740/
Feb 28, 2024 - Datasite is acquiring Sherpany, a provider software to manage board room meetings and communication.
0
sb:1422432114033788578
0
https://www.fool.com/earnings/call-transcripts/2024/02/27/macys-m-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Feb 27, 2024 - M earnings call for the period ending December 31, 2023.
0
fool:7826469271403034158
0
https://www.zacks.com/stock/news/2232570/macy-s-m-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2232570
Feb 27, 2024 - While the top- and bottom-line numbers for Macy's (M) give a sense of how the business performed in the quarter ended January 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:1340115893070391610
0
https://www.zacks.com/stock/news/2232544/macy-s-lowe-s-beat-in-q4-durable-goods-lower?cid=CS-ZC-FT-ahead_of_wall_street-2232544
Feb 27, 2024 - We have some grist for the trading mill ahead of the opening bell, but it's not likely to cause any meaningful tremors from this vantage point.
zc:5822950188673072325
0
https://www.zacks.com/stock/news/2228893/macy-s-m-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2228893
Feb 20, 2024 - In the most recent trading session, Macy's (M) closed at $19.26, indicating a -1.03% shift from the previous trading day.
zc:-2804028658648614471
0